Physician profile
John J Willems
NPI 1184664591
$4,249.19
in general payments reported to CMS, 2019-2025
18 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,666 · 2020: $12.29 · 2021: $13.75 · 2022: $51.80 · 2023: $149 · 2024: $247 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $3,244.77 | 2019 | |
| Astellas Pharma US INC | $220.73 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $148.48 | 2019 | |
| Mayne Pharma Commercial LLC | $131.12 | 2024-2025 | |
| Pfizer INC. | $84.03 | 2019 | |
| Allergan, INC. | $73.47 | 2019 | |
| Abbvie INC. | $68.26 | 2020-2023 | Lo Loestrin Fe |
| Becton, Dickinson and Company | $39.51 | 2023-2025 | Bd Onclarity |
| Hologic Sales and Service, LLC | $34.99 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Bayer Healthcare Pharmaceuticals INC. | $31.93 | 2019 | |
| Coopersurgical, INC. | $28.85 | 2023 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $25.65 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $23.73 | 2025 | Solosec, Phexx, Phexxi |
| Amag Pharmaceuticals, INC. | $23.32 | 2019 | |
| Myovant Sciences INC. | $22.76 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $18.25 | 2019 | |
| Avion Pharmaceuticals | $15.65 | 2019 | |
| Minerva Surgical, INC | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Willems listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.